We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Evolent Health
EVH
$423M
| $8.73M | 0.02% |
315,587
-140,368
| -31% | -$4.03M |
|
677
Kohl's
KSS
$1.87B
| $8.73M | 0.02% |
176,747
+12,801
| +8% | +$654K |
|
678
Vishay Intertechnology
VSH
$4.8B
| $8.71M | 0.02% |
398,062
+5,605
| +1% | +$115K |
|
679
Evercore
EVR
$10.1B
| $8.65M | 0.02% |
63,714
-343
| -0.5% | -$50K |
|
680
Traeger
COOK
$136M
| $8.63M | 0.02% |
14,200
| – | – |
|
681
Lowe's Companies
LOW
$109B
| $8.62M | 0.02% |
33,331
-11,601
| -26% | -$2.76M |
|
|
BCOV
682
DELISTED
Brightcove, Inc.
BCOV
| $8.6M | 0.02% |
841,666
+535,310
| +175% | +$5.64M |
|
683
Tencent Music
TME
$12.7B
| $8.6M | 0.02% |
+1,255,122
| New | +$9.25M |
|
|
NOVA
684
DELISTED
Sunnova Energy
NOVA
| $8.6M | 0.02% |
307,852
+110,852
| +56% | +$3.99M |
|
685
Boyd Gaming
BYD
$5.49B
| $8.56M | 0.02% |
130,549
-2,204
| -2% | -$140K |
|
|
CIM
686
Chimera Investment
CIM
$912M
| $8.54M | 0.02% |
188,815
+25,004
| +15% | +$1.18M |
|
|
NUVA
687
DELISTED
NuVasive, Inc.
NUVA
| $8.52M | 0.02% |
162,395
+34,503
| +27% | +$1.88M |
|
|
VRTV
688
DELISTED
VERITIV CORPORATION
VRTV
| $8.52M | 0.02% |
69,515
-236
| -0.3% | -$28.4K |
|
|
DNMR
689
DELISTED
Danimer Scientific, Inc.
DNMR
| $8.52M | 0.02% |
25,000
-3,257
| -12% | -$1.79M |
|
690
Vanda Pharmaceuticals
VNDA
$302M
| $8.51M | 0.02% |
542,664
-5,228
| -1% | -$91.1K |
|
691
Novartis
NVS
$264B
| $8.49M | 0.02% |
97,121
-20,445
| -17% | -$1.7M |
|
|
NLSN
692
DELISTED
Nielsen Holdings plc
NLSN
| $8.49M | 0.02% |
413,981
-13,070
| -3% | -$266K |
|
|
DCPH
693
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $8.49M | 0.02% |
+868,710
| New | +$16.3M |
|
694
Paycom
PAYC
$10.3B
| $8.48M | 0.02% |
20,434
-523
| -2% | -$248K |
|
695
Constellium
CSTM
$3.51B
| $8.46M | 0.02% |
472,423
-19,499
| -4% | -$358K |
|
|
VSTO
696
DELISTED
Vista Outdoor Inc.
VSTO
| $8.42M | 0.02% |
182,826
-1,819
| -1% | -$77.8K |
|
697
Treace Medical Concepts
TMCI
$297M
| $8.39M | 0.02% |
450,000
| – | – |
|
698
Halozyme
HALO
$12.3B
| $8.36M | 0.02% |
208,023
-113,693
| -35% | -$4.24M |
|
699
Simon Property Group
SPG
$65.7B
| $8.36M | 0.02% |
52,353
+10,340
| +25% | +$1.58M |
|
|
ACH
700
Accendra Health
ACH
$82.3M
| $8.36M | 0.02% |
192,105
+31,702
| +20% | +$1.24M |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.